220 related articles for article (PubMed ID: 19902332)
21. Catabolism of Fibromodulin in Developmental Rudiment and Pathologic Articular Cartilage Demonstrates Novel Roles for MMP-13 and ADAMTS-4 in C-terminal Processing of SLRPs.
Shu CC; Flannery CR; Little CB; Melrose J
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30700002
[TBL] [Abstract][Full Text] [Related]
22. Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes.
Sondergaard BC; Wulf H; Henriksen K; Schaller S; Oestergaard S; Qvist P; Tankó LB; Bagger YZ; Christiansen C; Karsdal MA
Osteoarthritis Cartilage; 2006 Aug; 14(8):759-68. PubMed ID: 16549372
[TBL] [Abstract][Full Text] [Related]
23. Selective MMP-13 Inhibitors: Promising Agents for the Therapy of Osteoarthritis.
Wan Y; Li W; Liao Z; Yan M; Chen X; Tang Z
Curr Med Chem; 2020; 27(22):3753-3769. PubMed ID: 30556497
[TBL] [Abstract][Full Text] [Related]
24. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
25. C2K77 ELISA detects cleavage of type II collagen by cathepsin K in equine articular cartilage.
Noé B; Poole AR; Mort JS; Richard H; Beauchamp G; Laverty S
Osteoarthritis Cartilage; 2017 Dec; 25(12):2119-2126. PubMed ID: 28882751
[TBL] [Abstract][Full Text] [Related]
26. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
27. The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review.
Mehana EE; Khafaga AF; El-Blehi SS
Life Sci; 2019 Oct; 234():116786. PubMed ID: 31445934
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis.
Barksby HE; Milner JM; Patterson AM; Peake NJ; Hui W; Robson T; Lakey R; Middleton J; Cawston TE; Richards CD; Rowan AD
Arthritis Rheum; 2006 Oct; 54(10):3244-53. PubMed ID: 17009259
[TBL] [Abstract][Full Text] [Related]
29. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
[TBL] [Abstract][Full Text] [Related]
30. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
31. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures.
Kozaci LD; Buttle DJ; Hollander AP
Arthritis Rheum; 1997 Jan; 40(1):164-74. PubMed ID: 9008612
[TBL] [Abstract][Full Text] [Related]
32. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.
Wu W; Billinghurst RC; Pidoux I; Antoniou J; Zukor D; Tanzer M; Poole AR
Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513
[TBL] [Abstract][Full Text] [Related]
33. Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.
Xie XW; Wan RZ; Liu ZP
ChemMedChem; 2017 Aug; 12(15):1157-1168. PubMed ID: 28722301
[TBL] [Abstract][Full Text] [Related]
34. The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritis.
Smith GN
Front Biosci; 2006 Sep; 11():3081-95. PubMed ID: 16720377
[TBL] [Abstract][Full Text] [Related]
35. SKI306X suppresses cartilage destruction and inhibits the production of matrix metalloproteinase in rabbit joint cartilage explant culture.
Kim JH; Ryu KH; Jung KW; Han CK; Kwak WJ; Cho YB
J Pharmacol Sci; 2005 Jul; 98(3):298-306. PubMed ID: 16034188
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes.
Tetlow LC; Adlam DJ; Woolley DE
Arthritis Rheum; 2001 Mar; 44(3):585-94. PubMed ID: 11263773
[TBL] [Abstract][Full Text] [Related]
37. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice.
Neuhold LA; Killar L; Zhao W; Sung ML; Warner L; Kulik J; Turner J; Wu W; Billinghurst C; Meijers T; Poole AR; Babij P; DeGennaro LJ
J Clin Invest; 2001 Jan; 107(1):35-44. PubMed ID: 11134178
[TBL] [Abstract][Full Text] [Related]
38. In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation.
Greenwald RA; Golub LM; Ramamurthy NS; Chowdhury M; Moak SA; Sorsa T
Bone; 1998 Jan; 22(1):33-8. PubMed ID: 9437511
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development.
Little CB; Barai A; Burkhardt D; Smith SM; Fosang AJ; Werb Z; Shah M; Thompson EW
Arthritis Rheum; 2009 Dec; 60(12):3723-33. PubMed ID: 19950295
[TBL] [Abstract][Full Text] [Related]
40. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.
Bau B; Gebhard PM; Haag J; Knorr T; Bartnik E; Aigner T
Arthritis Rheum; 2002 Oct; 46(10):2648-57. PubMed ID: 12384923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
